Author:
Blal Naym,Guarnieri Daniela
Reference20 articles.
1. Jain RK, Stylianopoulos T (2010) Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7:653–664
2. Hambley TW (2009) Is anticancer drug development heading in the right direction? Cancer Res 69:1259–1262
3. Tannock IF, Lee CM, Tunggal JK et al (2002) Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res 8:878–884
4. Peer D, Karp JM, Hong S et al (2020) Nanocarriers as an emerging platform for cancer therapy, 1st edn. Jenny Stanford Publishing, New York, pp 61–91
5. Injac R, Strukelj B (2008) Recent advances in protection against doxorubicin-induced toxicity. Technol Cancer Res Treat 7:497–516